Kits Eyecare Ltd. (KITS.TO)
| Previous Close | 5.63 |
| Open | 5.83 |
| Bid | 5.96 x N/A |
| Ask | 6.00 x N/A |
| Day's Range | 5.83 - 5.99 |
| 52 Week Range | 4.08 - 7.00 |
| Volume | |
| Avg. Volume | 18,165 |
| Market Cap | 187.381M |
| Beta (5Y Monthly) | 0.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 |
| Earnings Date | May 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.29 |
CNW GroupKITS Eyecare Sets First Quarter 2024 Conference Call for Wednesday, May 8, 2024, at 9:00 a.m. ET
Kits Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), a leading vertically integrated eyecare provider, will hold a conference call on Wednesday, May 8, 2024, at 9:00 a.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2024. The financial results will be reported in a press release prior to the conference call.
CNW GroupKITS Eyecare Hires Two Key Senior Finance Leaders
KITS Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), a leading vertically integrated eyecare provider, announced the appointments of Ibrahim Kamar as Senior Vice President of Finance and Allen Zhu as Controller, both effective April 2, 2024.
CNW GroupKITS Eyecare Announces Sabrina Liak will Transition to Senior Advisor Role and Continue as Board Member
KITS Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), a leading vertically integrated eyecare provider, today announced Sabrina Liak, the Company's President, has decided to transition to a strategic advisory role effective June 30, 2024, with plans to pursue new opportunities. Roger Hardy will continue to lead KITS as Chairman and CEO. Sabrina will maintain her position as Co-founder and Director on KITS' Board of Directors, while also assuming the role of Senior Advisor.
